Fiche centre
Artemis Institute for Clinical Research
Riverside — United States
Essais liés3clinical trials
VilleRiversidelocalisation
PaysUnited Stateslocalisation
SourcelocaleCSV/MySQL
Informations
centreImport ClinicalTrials.gov
Essais cliniques associés
3| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Partial Rebreathing Device | Migraine | Non applicable | NCT05546385 | PAREMA1 — PArtial REbreathing for Migraine With Aura 1 | TERMINATED |
| Elismetrep | Migraine | Phase 3 | NCT07645924 | A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine | RECRUITING |
| Elismetrep | Migraine | Phase 3 | NCT07674654 | A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine | RECRUITING |